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Abstract
Objectives: We aimed to assess the effect of  anemia on subjective sleep quality in patients with iron deficiency anemia 
(IDA). 
Methods: One hundred and four patients diagnosed with IDA and 80 healthy individuals, who are gender and age matched, 
were included in the study. All participants were requested to fill 3 forms: a socio-demographic form (age, gender, marital 
status, income level and educational status), hospital anxiety and depression (HAD) scale and pittsburgh sleep quality index 
(PSQI). 
Results: According to the HAD scale, the average anxiety score was found 9.24±4.37 in patients and 7.58± 4.07 in controls. 
And, the average depression score was 7.53±4.10 in patients and 6.41±2.74 in controls. The total sleep quality score was 
6.71±3.02 in patients and 4.11±1.64 in controls. There was a statistically significant difference in terms of  anxiety, depres-
sion and sleep quality scores. Linear regression analysis showed no association between anxiety and depression with poor 
sleeping.
Conclusion: IDA affects sleep quality irrespective of  psychological symptoms such as depression and anxiety.
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Introduction
After a negative iron balance in the body due to reasons 
such as chronic blood loss, increased iron demand, and 
absorption disorder, hemoglobin synthesis is compen-
sated by mobilization of  iron from stores and when the 
stores of  iron fail to release adequate iron, iron defi-
ciency anemia (IDA) develops1. Just like in our country, 
iron deficiency is the most common cause of  anemia in 
the world and is more prevalent in women than men2,3. 
It has been known that more than 30% of  those attend-
ing to hospitals in developed countries are anemic and 
the said ratio is much higher in developing countries.  
In developed countries, 3% of  adult males, 20% of  
adult females and 50% of  pregnant women have iron 
deficiency anemia4,5. Loss of  appetite, tiredness, pale 
skin, lethargy, headache, tinnitus and impairments in 
cognitive and intellectual functions can be observed in 
IDA6. Iron plays a key role in the metabolism of  mono-
amines in the brain thus iron deficiency leads to symp-
toms such as apathy, drowsiness, irritability and lack of  
attention occur due to impaired monoamine oxidase 
activity7. Patients affected from iron deficiency display 
many behavioral and emotional signs and have symp-
toms similar to the ones in depressive individuals8. 
Sleep is the period of  physiological, periodic and re-
versible changes in consciousness and behaviour9. It is 
defined as a reversible state where interaction of  the 
organism with the environment is lost temporarily, par-
tially and periodically10. Nearly 30-33% of  the society 
has a significant sleep problem. The said ratio is higher 
in older adults, those having a psychiatric disorder and 
specific groups with learning difficulties11-14. In various 
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studies, advanced age, female gender, stress, depression, 
anxiety, alcohol, substance abuse and physical diseases 
are the important factors causing sleep disorders15,16.
Due to the key role of  iron in the metabolism of  mon-
oamines in the brain and the role of  the same monoam-
ines in sleep physiology, we stipulated that sleep quality 
might deteriorate in IDA. In this context, studies usual-
ly have been performed in pediatric populations. To the 
best of  our knowledge, there exist no studies examin-
ing subjective sleep quality in adult patients with IDA. 
Therefore, we aimed evaluating sleep quality in adult 
patients diagnosed with IDA.
Materials and methods
Our study is a prospective and cross-sectional study 
which has been carried out at Cumhuriyet Universi-
ty, medical faculty, hematology clinic between January 
2013 and June 2013. Ethical committee approval was 
obtained from the ethics commitee of  the medical fac-
ulty of  Cumhuriyet University, and the study was in 
accordance with the declaration of  Helsinki. One hun-
dred and four patients diagnosed with IDA and  gender 
and age matched 80 healthy individuals were included in 
the study.  Loss of  appetite and tiredness were the most 
common presentations. It was confirmed that there 
were no accompanying neurological or endocrinologi-
cal diseases in patients with IDA. 
The diagnosis of   IDA was made by evaluating the levels 
of  hemoglobin, transferrin saturation -calculated by the 
ratio of  serum iron to serum iron binding capacity- and 
ferritin. Hemoglobin level below 13 mg/dL in men and 
12 mg/dL in women, transferrin saturation ratio below 
15%, and ferritin level below 15 ng/mL indicated IDA. 
The control group was composed of  healthy volunteers 
who were regular blood donors in our hospital. Those 
having systemic diseases such as diabetes mellitus, hy-
pertension, congestive heart failure, chronic obstructive 
pulmonary disease, coronary artery disease, rheumatoid 
arthritis, systemic lupus erythematosus and ankylosing 
spondylitis and any medication use were excluded from 
the study. The participants were asked to complete a 
socio-demographic form (age, gender, marital status, 
income level and educational status), hospital anxiety 
and depression scale and Pittsburgh sleep quality index. 
Anxiety and depression parameters were tested by the 
hospital anxiety and depression scale (HAD). As the 
scores increase, depression and anxiety increase16-17. 
The Turkish version was developed by Aydemir18 et al. 
The Pittsburgh sleep quality index (PSQI) was used to 
measure sleep disturbance. It is consisted of  19 items 
and over 7 domains that include subjective sleep quality, 
sleep latency, sleep duration, habitual sleep efficiency, 
sleep disturbance, use of  sleep medications and day-
time dysfunction. Greater PSQI scores show worse 
sleep quality. A global sum of  6 or greater indicates a 
“poor” sleeper17-19. The Turkish version was developed 
by Agargun20 et al.
Statistical analysis 
SPSS 15.0 statistical program (SPSS, version 15.0 for 
Windows; SPSS, Chicago, IL, USA) was used for sta-
tistical analysis. Continuous variables are presented as 
means ± SDs, and categorical variables are presented as 
percentages. Independent-sample t- test were used to 
compare patients and healthy individuals with regard to 
the study variables. Chi-square tests were used to com-
pare data presented as percentages. Correlation analysis 
was performed using Pearson’s coefficient of  correla-
tion. Linear regression analysis was utilized to assess the 
contributions of  age, anxiety, and depression to poor 
sleeping.
Results
The patient population (average age: 32.57 ±10.19 
years) were composed of  104 patients [81 (77.9%) fe-
male and 23 (22.1%) male]. The control group (average 
age: 30.44 ± 9.98 years)  had similar socio-demograph-
ic characteristics and were composed of  80 healthy 
individuals [61 (76.2%) female and 19 (23.8%) male]. 
In terms of  age and gender distribution, there was no 
statistically significant difference between the groups 
(t=1.42 p=0.16 ve x²=0.069 p=0.793). The socio-de-
mographic characteristics of  the study groups are given 
in Table 1.
In terms of  haemoglobin, hematocrit and MCV val-
ues, there was a statistically significant difference be-
tween the groups (t=16.95, p=0.001; t=6.77, p=0.001; 
t=15.78, p=0.001, respectively). The other hemogram 
parameters did not show any differences between the 
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groups. The detailed hemogram values of  the groups 
are shown in Table 2. In the patient group, the average 
serum ferritin level and total iron binding capacity were 
measured as 7.15±5.28 and 412.10±60.4, respectively. 
In HAD scale, the average anxiety score was found 
Table 2. Hemogram values 
 Patients 
mean ± SD 
Controls 
mean ± SD 
T p 
Haemoglobin 10.05 ± 1.47 13.12 ± 0.76 16.96 0.001* 
Hematocrit 32.62 ± 3.64 36.11 ± 3.21 6.77 0.001* 
MCV 70.28 ± 7.84 85.24 ± 3.67 15.78 0.001* 
White Blood Cell  6.31 ± 1.37 6.16 ± 1.48 0.67 0.504 
MCH 21.93 ± 3.43 21.81 ± 3.31 0.04 0.958 
MCHC 30.90 ± 3.28 31.07 ± 3.60 0.33 0.741 
*p<0.05, significant 
MCV: mean corpuscular volume 
MCH: mean corpuscular hemoglobin  
MCHC: mean corpuscular hemoglobin concentration 
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9.24±4.37 in patients and 7.58±4.07 in controls (t=2.64, 
p=0.009). The average depression score was 7.53±4.10 
in patients and 6.41±2.74 in controls (t=2.10, p=0.037). 
There was a statistically significant difference in terms 
of  anxiety and depression scores. The number of  pa-
tients who had an anxiety level above the cut-off  score 
was 45 (43.3%) and it was 22 (27.5%) in the control 
group (x²= 4.856 p=0.028). The number of  patients 
who had a depression score above the cut-off  score was 
49 (47.1%) and it was 26 (32.5%) in the control group 
(x²=4.00, p=0.045).
In PSQI, 70 (67.3%) patients and 32 (40.5%) controls 
reported a bad sleep quality. The number of  patients 
who reported a bad sleep quality were statistically signif-
icantly higher than the controls (x²=13.072;  p<0.001). 
The total sleep quality score was 6.71±3.02 in patients 
and 4.11±1.64 in controls. In terms of  total PSQI score, 
there was a statistically significant difference between 
the groups (t= 6.94, p<0.001).
With respect to the subscales of  PSQI, subjective sleep 
score was found 1.33±0.81 in patients and 0.85±0.58 in 
controls, so, we have found a statistically significant dif-
ference between groups (t= 4.48,  p<0.001). Sleep dis-
order score was 1.63±0.75 in patients and 0.93±0.57 in 
controls, so, we have found a statistically significant dif-
ference between groups (t=7.04, p<0.001). PSQI sucb-
scale scores of  the groups are given in Table 3. In the 
regression analysis, we evaluated whether the presence 
of  “sleep disorder” is associated with depression and 
anxiety. Linear regression analysis showed no associa-
tion of  anxiety (partial correlation coefficient: -0.176; p 
= 0.101) and depression (partial correlation coefficient: 
-0.086; p = 0.430) with poor sleeping.
Table 3. PSQI subscales  
              *p<0.05, significant 
 
 Patients 
(mean ± SD)   
Controls 
(mean ± SD) 
         Statistics  
    (t)                    (p)
Subjective sleep quality 1.33 ± 0.81 0.85 ± 0.58 4.48 0.001* 
Sleep latency 1.33 ± 0.81 0.73 ± 0.64 5.49 0.001* 
Sleep duration 0.62 ± 0.84 0.56 ± 0.59 0.48 0.632 
Habitual sleep efficiency 0.60 ± 0.77 0.38 ± 0.51 2.22 0.028* 
Sleep disturbances 1.63 ± 0.75 0.93 ± 0.57 7.04 0.001* 
Use of sleep medication 0.02 ± 0.20 0.00 ± 0.00 0.88 0.382 
General dysfunction 1.19 ± 0.89 0.68 ± 0.63 4.40 0.001* 
Total sleep disorder 6.71 ± 3.02 4.11 ± 1.64 6.94 0.001* 
Discussion
Iron deficiency has been reported to cause behavioral 
and developmental symptoms by affecting transmitters 
such as serotonin, noradrenaline and dopamine, mye-
lination, and the metabolic activity in the neurons21,22. 
It has been also reported that brain functions such as 
cognition and learning are affected in patients with 
IDA23. Peirano et al.24 reported that relative to controls, 
children with IDA showed: a) longer duration of  REM 
sleep episodes in the first third and shorter in the last 
third; b) more REM sleep episodes in the first third and 
fewer in the second third; and c) shorter latency to the 
first REM sleep episode and shorter NREM stage 2. So, 
their results show that IDA is associated with long-last-
ing alterations in the temporal organization of  sleep 
patterns24. Peirano et al.24 suggested that the changes in 
the neurotransmitter metabolism due to iron deficiency, 
pscyhological status or a possible restless leg syndrome 
(RLS) affected sleep negatively. These results could be 
explained by some mechanisms. One possible explana-
tion for the differences that long-lasting effects of  iron 
deficiency on the developing dopamine (DA) system 
are a promising example25,26. 
Iron has a complex effect on dopaminergic function. It 
is a cofactor for tyrosine hydroxylase and is integral to 
D2 receptor function27. Neuromodulation by the DA 
system plays an important role in sleep regulation, in-
cluding the modulation of  REM sleep quality, quantity, 
and timing28,29. Holst et al.30, studied sleep–wake regu-
lation in humans and combined pharmacogenetic and 
neurophysiologic methods to analyze the effects of  the 
3′-UTR variable-number-tandem-repeat polymorphism 
of  the gene (DAT1, SLC6A3) encoding dopamine 
transporter. Their findings suggested that the dopamine 
transporter contributes to homeostatic sleep–wake reg-
ulation in humans. Fifel et al.31, investigated alterations 
of  circadian rhythms in non-human primate models 
following lesion of  the dopaminergic nigro-striatal sys-
tem. 
Their results are of  clinical importance and stress that 
sleep/wake disturbances associated with DA loss may 
be more severely affected than previously thought, in 
particular in sub-optimal lighting conditions. The dy-
namic balance between neurotransmitter systems is 
another important consideration. The ultradian al-
ternation of  NREM sleep/REM sleep appears to be 
controlled by a permanent interacting balance between 
brainstem aminergic and cholinergic neuronal dis-
charges32. An additional explanation could be differing 
amounts of  sleep alterations. In particular, RLS and pe-
riodic limb movements during sleep have been associat-
ed with conditions characterized by compromised iron 
status33. It has been known that iron deficiency plays 
an important role in the physiopathology of  the RLS 
characterized by an irresistible urge to move legs as well 
as motor restlessness.
Iron treatment has been thought to increase sleep qual-
ity of  the patients by decreasing RLS complaints. In a 
study of  Allen et al.34, prevalence of  clinically signif-
icant RLS (RLS sufferers) was 23.9% in 251 patients 
with IDA, nine times higher than the general popula-
tion. In another study, the said ratio was reported as 
40%35. Patients with RLS were excluded from this study. 
In the present study, nearly 68% of  the patients with 
IDA were shown to have an impaired sleep quality. Our 
findings support the idea that sleep quality is impaired 
in a significant portion of  patients with IDA. 
Depression and anxiety disorders are among the psy-
chological disorders that affect sleep quality negatively. 
In a study conducted by Onder et al., depressive dis-
order was found to be a common disorder in patients 
with anemia36. In our study, similar to the literature, a 
major portion (nearly 45%) of  the patients had high 
anxiety and depression scores. Son et al. reported that 
cognitive functions were worse in anemia patients when 
compared to healthy controls, which was shown to be 
associated with depressive disorder37. In the present 
study, logistic regression analysis showed that anemia 
affected sleep quality irrespective of  the psychological 
symptoms.
To the best of  our knowledge, there is no study in the 
literature that evaluated the association between labora-
tory values and sleep quality in adult population having 
IDA. Yehuda and collageus38, examined hemoglobin 
levels and showed that sleep-deprived attention deficit 
hyperactivity disorder (ADHD) patients also suffer also 
from iron deficiency. However, Yehuda et al.38, were 
not clear if  iron deficiency was one of  the core symp-
toms of  this pediatric group or it was a consequence 
of  poor food intake habits. Another study of  the Ye-
huda39, showed that iron deficiency might be associated 
with sleep disturbances and lower intelligence quality at 
pediatric population. 
We have found no significant relation between the 
sleep quality and laboratory values of  the patients. In 
our study, lack of  significant correlation between lab-
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oratory values and sleep quality scores was not an ex-
pected result. Shariatpanaahi et al.40 reported that there 
was a weak correlation between serum ferritin level and 
depression. In another study, it was shown that serum 
ferritin and hemoglobin levels had no significant rela-
tion with depression level. Similar to the results of  the 
previous studies, the results of  our study showed that 
the sleep quality level could not be evaluated through 
hemogram, serum iron and ferritin levels in patients 
with IDA.
Limitations
Our study had some limitations. The first limitation was 
evaluating depression anxiety and sleep quality through 
self-report scales. The second limitation was not per-
forming polysomnographic measurements. There is a 
possible discrepancy between objective sleep evaluation 
(by EEG or by Actigraph) and subjective evaluation 
(PSQI). Conducting a cross-sectional study could have 
affected the results, too.
Conclusion 
Subjective sleep quality was evaluated in patients with 
IDA in the present study. The results showed that IDA 
affects sleep quality irrespective of  psychological symp-
toms such as depression and anxiety. And also, it was 
shown that subjective sleep quality was worse in pa-
tients with IDA when compared to the healthy controls. 
The effects of  anemia treatment on sleep quality were 
not assessed due to the cross-sectional nature of  the 
study. Further studies, where anemia patients should be 
followed-up for an extended period of  time and evalu-
ated by polysomnography, are required. 
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